These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2901077)
41. The pharmacologic absis for the control of motion sickness by drugs. Brand J Pharmacol Physicians; 1968 Mar; 2(3):1-5. PubMed ID: 4384429 [No Abstract] [Full Text] [Related]
42. The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time. Howland J; Rohsenow DJ; Minsky S; Snoberg J; Tagerud S; Hunt SK; Almeida A; Greece J; Allensworth-Davies D Int J Occup Environ Health; 2008; 14(4):250-6. PubMed ID: 19043911 [TBL] [Abstract][Full Text] [Related]
43. Effects of transdermal scopolamine upon psychological test performance at sea. Parrott AC; Jones R Eur J Clin Pharmacol; 1985; 28(4):419-23. PubMed ID: 4029247 [TBL] [Abstract][Full Text] [Related]
44. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea. Noy S; Shapira S; Zilbiger A; Ribak J Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687 [TBL] [Abstract][Full Text] [Related]
45. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness. Pingree BJ; Pethybridge RJ Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125 [TBL] [Abstract][Full Text] [Related]
47. Prevention of experimental motion sickness by scopolamine absorbed through the skin. Graybiel A; Knepton J; Shaw J Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234 [TBL] [Abstract][Full Text] [Related]
48. Histaminergic response to Coriolis stimulation: implication for transdermal scopolamine therapy of motion sickness. Wang ET; Zhou DR; He LH Aviat Space Environ Med; 1992 Jul; 63(7):579-82. PubMed ID: 1616432 [TBL] [Abstract][Full Text] [Related]
51. The prevention of seasickness with hyoscine, benadryl, and phenergan. GLASER EM; HERVEY GR Lancet; 1951 Oct; 2(6687):749-53. PubMed ID: 14874498 [No Abstract] [Full Text] [Related]
52. Angel's Trumpet psychosis: a central nervous system anticholinergic syndrome. Hall RC; Popkin MK; Mchenry LE Am J Psychiatry; 1977 Mar; 134(3):312-4. PubMed ID: 842711 [TBL] [Abstract][Full Text] [Related]
53. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations. Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260 [TBL] [Abstract][Full Text] [Related]
56. [Prevention of kinetosis in children. Transdermal therapy with scopolamine]. Müller M; Besch W; Steilner D Fortschr Med; 1987 Feb; 105(4):82, 86-7. PubMed ID: 3557264 [No Abstract] [Full Text] [Related]
57. The effects of scopolamine and cyclizine on visual-vestibular interaction in humans. Gowans J; Matheson A; Darlington CL; Smith PF J Vestib Res; 2000; 10(2):87-92. PubMed ID: 10939683 [TBL] [Abstract][Full Text] [Related]
58. Safety of double-dose transdermal scopolamine. Bar R; Gil A; Tal D Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013 [TBL] [Abstract][Full Text] [Related]
59. Promethazine-induced psychosis in a 16-year-old girl. Timnak C; Gleason O Psychosomatics; 2004; 45(1):89-90. PubMed ID: 14709767 [No Abstract] [Full Text] [Related]